MBIO - Mustang Bio Inc
Mustang Bio Inc Logo

MBIO - Mustang Bio Inc

https://www.mustangbio.com
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, is focused on translating medical advances in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The company is headquartered in Worcester, Massachusetts.

52W High
$18.50
52W Low
$0.95
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
2.23
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
0.72
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.14
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
3.58
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
3.16%
Institutions (25–75% balanced)
3.18%
Shares Outstanding
6,394,300
Float
6,192,500
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
-50,000
Gross Profit (TTM)
0
EPS (TTM)
1.99
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-11.91%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Value
N/A
Previous
N/A
Trend
—
Signal Cross
No cross
As of
—